Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study

Table 3 McNemar’s test of pre- versus post-baseline hospitalizations^a

	Post-baseline Hospitalization
Previous Hospitalization^b	No	Yes	P-value
No, n (%)	183 (63.5)	11 (3.8)	<0.001
Yes, n (%)	81 (28.1)	13 (4.5)

Abbreviation: LAI long-acting injection, SD standard deviation
^aAnalysis included only patients who started treatment with at least 1 injection of olanzapine LAI at time of study entry, without baseline hospitalization, and who had opportunity for at least 6 months of follow-up
^bAnalysis included hospitalization in the 6 months prior to initiating olanzapine LAI treatment

ISSN: 1471-244X